Pulmonary surfactant is a developmentally and hormonally regulated lipoprotein synthesized exclusively in alveolar type II cells. Surfactant protein-A (SP-A) gene transcription in human fetal lung in culture is stimulated by glucocorticoids and cAMP; cAMP also enhances the rate of type II cell differentiation. The CCAAT/enhancer-binding protein (C/EBP) family of transcription factors serves an important role in the regulation of genes involved in energy metabolism, lipid biosynthesis, and cellular differentiation. The gene encoding C/EBP␦, which is induced by glucocorticoids during the early phases of adipocyte differentiation, is expressed at relatively high levels in lung compared with other tissues. In the present study we have analyzed developmental changes in C/EBP␦ messenger RNA levels in fetal rabbit lung as well as changes in the levels of immunoreactive C/EBP␦ in human fetal lung during differentiation in organ culture and after treatment with cAMP and glucocorticoids. We observed that C/EBP␦ messenger RNA is detectable in fetal rabbit lung on day 19 of gestation and is increased ϳ3.7-fold to maximum levels on day 28 of gestation, the time when SP-A gene transcription increases to maximum levels. Immunohistochemical analysis of C/EBP␦ in midgestation human fetal lung before culture revealed trace nuclear staining in epithelial and occasional stromal cells. After 12 h of organ culture in serum-free medium, nuclear staining of C/EBP␦ was markedly increased in epithelial cells lining the prealveolar ducts of the human fetal lung tissue. By immunoblot analysis, it was found that C/EBP␦ levels were induced rapidly during organ culture in control medium and were increased further by treatment with dexamethasone and (Bt) 2 cAMP. C/EBP␦ levels were maximally induced during the first 24 h of culture and declined thereafter; after 72 h of incubation in control or cAMP-containing medium, C/EBP␦ was reduced markedly. By contrast, in fetal lung tissues incubated in medium containing dexamethasone or dexamethasone plus (Bt) 2 cAMP, the decline in C/EBP␦ was more modest, so that levels remained elevated throughout the 96-h culture period. Our findings that C/EBP␦ is localized primarily to alveolar epithelial cells, rapidly induced during differentiation of human fetal lung in culture, and increased by cAMP and glucocorticoids suggest a possible role in the regulation of type II cell differentiation and in the synthesis of surfactant phospholipids and proteins. (Endocrinology 138: [5527][5528][5529][5530][5531][5532][5533][5534] 1997) 
C/EBP␦ in midgestation human fetal lung before culture revealed trace nuclear staining in epithelial and occasional stromal cells. After 12 h of organ culture in serum-free medium, nuclear staining of C/EBP␦ was markedly increased in epithelial cells lining the prealveolar ducts of the human fetal lung tissue. By immunoblot analysis, it was found that C/EBP␦ levels were induced rapidly during organ culture in control medium and were increased further by treatment with dexamethasone and (Bt) 2 cAMP. C/EBP␦ levels were maximally induced during the first 24 h of culture and declined thereafter; after 72 h of incubation in control or cAMP-containing medium, C/EBP␦ was reduced markedly. By contrast, in fetal lung tissues incubated in medium containing dexamethasone or dexamethasone plus (Bt) 2 cAMP, the decline in C/EBP␦ was more modest, so that levels remained elevated throughout the 96-h culture period. Our findings that C/EBP␦ is localized primarily to alveolar epithelial cells, rapidly induced during differentiation of human fetal lung in culture, and increased by cAMP and glucocorticoids suggest a possible role in the regulation of type II cell differentiation and in the synthesis of surfactant phospholipids and proteins. (Endocrinology 138: 5527-5534, 1997) P ULMONARY surfactant is a developmentally regulated, phospholipid-rich lipoprotein produced exclusively by type II cells of the pulmonary alveolus, where it is stored as lamellar bodies. Surfactant is secreted into the lumen of the pulmonary alveolus, where surfactant phospholipids and proteins act to reduce surface tension and prevent alveolar collapse. Surfactant glycerophospholipid synthesis is initiated in fetal lung after ϳ75% of gestation is completed (1) . In prematurely born infants, inadequate surfactant synthesis can result in respiratory distress syndrome, a major cause of neonatal morbidity and mortality (2) . The major and most surface-active glycerophospholipid in surfactant is dipalmitoylphosphatidylcholine (3) . Surfactant also contains a number of proteins, surfactant protein-A (SP-A), SP-B, SP-C, and SP-D, that are lung specific and developmentally regulated in fetal lung tissue (4) . Whereas expression of the genes encoding SP-B and SP-C are initiated in human fetal during midgestation (5), SP-A gene expression is initiated during the third trimester, in concert with augmented glycerophospholipid synthesis (6, 7) . SP-D gene expression is initiated in the fetal lung just before birth (8) .
In previous studies we found that lung explants from midtrimester human abortuses differentiate spontaneously when maintained in organ culture in serum-free defined medium (9) . Within several days of culture, there is enlargement of the prealveolar ducts, appearance of differentiated type II cells containing lamellar bodies and induction of synthesis of surfactant glycerophospholipids and SP-A (9, 10). The rate of enlargement of the prealveolar ducts, the appearance of differentiated type II cells, and the induction of SP-A gene transcription are enhanced by cAMP treatment (11) . There are two SP-A genes in the human, SP-A1 and SP-A2 (12, 13) . The SP-A2 gene is more highly regulated by cAMP and during development than that encoding SP-A1 (14) . Within the 5Ј-flanking region of the human SP-A2 gene, we have identified enhancer elements that are functionally required for elevated basal and cAMP induction of SP-A2 promoter activity in type II cells (15, 16) .
Glucocorticoids in combination with insulin or insulin plus PRL increase the rate of surfactant glycerophospholipid synthesis in midgestation human fetal lung in organ culture (17) . Glucocorticoids also increase SP-A gene transcription in human fetal lung explants when added alone and act synergistically with cAMP (18, 19) ; however, the molecular basis for this regulation is not understood, as we have been unable to identify a functional glucocorticoidresponsive element (GRE) within the 5Ј-flanking sequence of the human SP-A2 gene (Young, P. P., and C. R. Mendelson, unpublished observations). Paradoxically, glucocorticoids cause a dose-dependent decrease in the steady state levels of SP-A messenger RNA (mRNA) in human fetal lung in culture (20) due to a dominant inhibitory effect on SP-A mRNA stability (19) .
The CCAAT/enhancer-binding protein (C/EBP) family of transcription factors has been postulated to serve a role in adipocyte differentiation (21, 22) . Furthermore, members of this family are expressed at relatively high levels in tissues that have the capacity to synthesize, store, and metabolize lipids at exceptionally high rates, including adipose tissue, liver, placenta, small intestine, and lung (23) . There are three major isoforms of C/EBP: ␣, ␤, and ␦; each is encoded by a distinct intronless gene (24, 25) . Whereas C/EBP␣ is expressed at highest levels in liver and adipose tissues, C/EBP␤ expression is more ubiquitous, although it is detected at the highest levels in intestine, liver, lung, and adipose tissues (25) . On the other hand, C/EBP␦ is expressed at highest levels in lung, with lower levels in intestine and adipose tissues (23, 25) . It has been suggested by McKnight and colleagues that C/EBPs may modulate the transcription of genes involved in energy metabolism (23, 26) . In light of their expression in lung, it was suggested that these factors may act to regulate genes involved in surfactant glycerophospholipid metabolism (23) .
Recently, it was reported that C/EBP␣ mRNA and protein are present in rat pulmonary type II cells, and that C/EBP␣ expression in fetal rat lung is developmentally induced on day 20 of gestation (27) subsequent to the appearance of differentiated type II cells and the initiation of synthesis of surfactant glycerophospholipids and of surfactant proteins SP-A, SP-B, and SP-C (28). Interestingly, mice carrying a homozygous mutation of the C/EBP␣ gene die at birth from severe hypoglycemia, not from respiratory distress (29) . Their lungs are described as being morphologically immature due to the presence of multicellular layers of epithelial cells lining the alveolar ducts (30) . Based on these findings, it is likely that C/EBP␣ serves to maintain a quiescent state and restrict type II cell proliferation rather than to regulate the expression of enzymes involved in surfactant glycerophospholipid synthesis.
In consideration of the relatively high levels of expression of C/EBP␦ in lung compared with those in other tissues and its hormonal induction during the early stages of adipogenesis (25) , in the present study we have analyzed developmental changes in C/EBP␦ mRNA levels in fetal rabbit lung as well as changes in the levels of immunoreactive C/EBP␦ in human fetal lung during differentiation in organ culture and after treatment with cAMP and glucocorticoids.
Materials and Methods

Organ culture
Lung tissues from human abortuses of ϳ14 -18 weeks gestation were obtained in accordance with the Donors Anatomical Gift Act of the State of Texas. Consent forms and protocols were approved by the human research review committee at the University of Texas Southwestern Medical Center (Dallas, TX). Fetal lung explants were maintained in serum-free Waymouth's MB752/1 medium (changed daily) as previously described and incubated in the absence or presence of (Bt) 2 cAMP (1 mm), dexamethasone (10 Ϫ10 -10 Ϫ7 m), or (Bt) 2 cAMP plus dexamethasone for periods up to 5 days (9). Each experiment was performed using pooled lung tissues from one to three human abortuses. For the data shown in Fig. 2B , each experiment was repeated using five independent human fetal lung tissues or pools of lung tissues. The scanned data shown in Fig. 3B are from three independent experiments using tissues from three different human abortuses or pools of lung tissue from several fetuses.
Isolation of RNA and Northern blot analysis of C/EBP␦ mRNA
Total RNA was isolated from fetal and adult rabbit lung tissue by homogenization in guanidinium isothiocyanate (4.0 m) and centrifugation through a cesium chloride (5.7 m) gradient as described previously (31, 32) . Total RNA (30 g) was size-fractionated on agarose-formaldehyde gels and transferred to Zeta-Probe membranes (Bio-Rad, Richmond, CA). Northern analysis was performed using standard protocols (33) and a complementary DNA (cDNA) probe specific for mouse C/EBP␦ (25) (provided by Dr. Steve McKnight, University of Texas Southwestern Medical Center) that was radiolabeled with phosphorus-32 using a random primed DNA labeling kit (Boehringer Mannheim, Indianapolis, IN). The relative levels of C/EBP␦ were assessed by autoradiography using intensifying screens, quantitated using a computing densitometer (Molecular Dynamics, Sunnyvale, CA) and corrected for loading and transfer after reprobing and scanning the blots for 18S ribosomal RNA. Protocols for research using pregnant rabbits were approved by the institutional animal care and research advisory committee, University of Texas Southwestern Medical Center.
Immunoblot analysis
Lung explants that were maintained in culture for various periods of time were homogenized in water (0 -2 C) containing phenylmethylsulfonylfluoride (1 mm). Crude nuclear and supernatant fractions were obtained after centrifugation of the homogenates at 600 ϫ g. We observed by both immunoblotting (unpublished observations) and immunocytochemistry ( Fig. 5 ) that the majority of C/EBP␦ immunoreactivity was present in the nucleus. Proteins (40 g) from the nuclear pellet were, therefore, separated on 11% SDS-polyacrylamide gels and transferred to nitrocellulose membranes as described previously (11) . The membranes were then analyzed for C/EBP␦ using specific rabbit polyclonal antibodies raised against the full-length protein (provided by Dr. Steven McKnight, University of Texas Southwestern Medical Center) and an Enhanced Chemiluminescence System (ECL) according to manufacturer's recommendations (Amersham, Arlington Heights, IL). This was followed by autoradiography and analysis via computing densitometry, as noted above. On all immunoblots performed, the polyclonal antiserum to C/EBP␦, which was raised against the full-length C/EBP␦ protein, reacted only with a single protein species of ϳ32 kDa, the predicted size of C/EBP␦. Furthermore, when this antiserum was used to probe immunoblots of equivalent amounts of peptides corresponding to sequences at or near the carboxy-termini of C/EBP␣, -␤, and -␦, the antiserum reacted only with the C/EBP␦ peptide.
Immunohistochemistry
Lung explants were fixed in 10% buffered formalin and routinely processed for light microscopy. Paraffin sections (3 m) were processed through graded alcohols, treated with 3% H 2 O 2 for 30 min, and subjected to microwave antigen retrieval for 10 min in Antigen Retrieval Citra solution (Biogenex, San Ramon, CA) before overnight incubation with the rabbit polyclonal antiserum for C/EBP␦ (1:500 dilution). Immuno-reactivity was detected by streptavidin-biotin methodology, using biotinylated antirabbit IgG and diaminobenzidine as chromagen (Dako, Carpenteria, CA). Adjacent sections were analyzed concurrently using nonimmune rabbit serum in place of C/EBP␦ antiserum as negative controls.
Results
C/EBP␦ mRNA levels are increased in fetal rabbit lung tissue during development
To study developmental changes in C/EBP␦ expression, we analyzed C/EBP␦ mRNA levels in lung tissues from fetal rabbits from 19 -30 days gestational age (term ϭ 31 days) and from adult rabbits by Northern blotting. The rabbit provides a suitable model for such studies because of its relatively long gestation period (term ϭ 31 days). We have found that SP-A gene transcription is increased in fetal rabbit lung tissue by day 24 of gestation and reaches maximal levels by day 28 (34) . We elected to use Northern analysis rather than immunoblotting for these developmental studies because the C/EBP␦ polyclonal antiserum used for immunoblot analysis was raised in rabbits, and the second antibody used (antirabbit IgG) cross-reacts with IgG in rabbit tissues. A representative Northern blot and quantitation of the densitometric scans of four different Northern blots corrected for loading and transfer of RNA are shown in Fig. 1, A and B, respectively. As can be seen, C/EBP␦ mRNA was detectable in lung tissues of 19-day gestation fetal rabbits, increased ϳ3-fold by day 21, and reached maximal levels by day 28 of gestation. The levels of C/EBP␦ mRNA in adult rabbit lung were comparable to those in the 28-day gestation fetal lung tissue. The maximum induction of C/EBP␦ mRNA in fetal rabbit lung on day 28 of gestation is coincident with the time that increased numbers of type II cells and increased surfactant phosphatidylcholine synthesis are observed (1) and when SP-A gene transcription reaches its maximum level (34) .
C/EBP␦ expression is induced during differentiation of human fetal lung in culture and is stimulated by glucocorticoids and cAMP
We previously observed that lung tissues from 14-to 18-week gestation human fetuses spontaneously differentiate in organ culture in serum-free medium. Within 2 days of incubation, there is appearance of differentiated type II cells that synthesize surfactant glycerophospholipids and SP-A (9, 11). The rate of appearance of type II cells and of SP-A gene transcription are induced to higher levels by cAMP treatment (11) . Furthermore, glucocorticoids act synergistically with cAMP to increase SP-A gene transcription (18, 19) . In consideration of these findings, it was of interest to study C/EBP␦ expression before and after differentiation of midgestation human fetal lung in organ culture as well as the effects of glucocorticoids and cAMP analogs. In Fig. 2A is a representative immunoblot of C/EBP␦ in midgestation human fetal lung tissue before culture (0) and after 1, 3, and 5 days of organ culture in the absence (control) or presence of (Bt) 2 cAMP (1 mm) and dexamethasone (10 Ϫ7 m), added either alone or in combination. In Fig. 2B are the combined data from five independent experiments. The scanned values are the mean Ϯ sem of three to five data points for each treatment group at each time point from each of these independent experiments [the one exception, (Bt) 2 cAMP-treated tissue after 1 day of culture, includes only two data points, which are presented as two dots]. The scanned values for each independent experiment were normalized to those of (Bt) 2 cAMPtreated tissues on day 5 of culture, which were given an arbitrary value of 1500. In fetal lung tissues incubated in control medium for 1 day, the levels of a single immunoreactive protein of approximately 32,000 M r , consistent with that of C/EBP␦, were comparable to those in the fetal lung tissues before culture (0). After 1 day of incubation, (Bt) 2 cAMP and dexamethasone each had a modest effect to increase C/EBP␦ levels compared with those in control tissues; in fetal lung tissues incubated with both agents in combination, C/EBP␦ rose to levels ϳ2-fold greater than control values. After 3-5 days of culture, the levels of C/EBP␦ were decreased in control and (Bt) 2 cAMP-treated tissues compared with those on day 1. By contrast, in dexamethasone-treated fetal lung explants and in lung tissues incubated with (Bt) 2 cAMP plus dexamethasone, the decline in C/EBP␦ as a function of incubation time was less pronounced. As a consequence, after 5 days of incubation, C/EBP␦ levels were increased more than 2-fold in dexamethasone-treated fetal lung tissues and ϳ3-fold in tissues incubated with dexamethasone plus (Bt) 2 cAMP compared with levels in control   FIG. 1 . Developmental changes in C/EBP␦ mRNA levels in rabbit lung tissue. Aliquots of total RNA (30 g) isolated from lung tissues of 19-to 30-day gestation fetal and adult rabbits were analyzed by Northern blotting using a C/EBP␦ cDNA probe. The blots were reprobed for 18S ribosomal RNA to correct for RNA loading and transfer. Shown in A is an autoradiogram of a representative Northern blot probed with radiolabeled C/EBP␦ cDNA. In B are plotted the mean Ϯ SEM values from four independent Northern blots corrected for loading and transfer of RNA. In each of the four gestational age series of blots analyzed, the corrected values are expressed relative to the values obtained for the 19-day gestation samples, which are give an arbitrary value of 100.
tissues at the corresponding time points (Fig. 2B) . It should be noted that the values obtained by densitometric scanning of autoradiograms may not strictly be linear and could result in an underestimation of the inductive effects of dexamethasone and (Bt) 2 cAMP; however, the differences observed among treatment groups were consistent from one experiment to another.
To further investigate the glucocorticoid induction of C/EBP␦ expression, we analyzed the effects of dexamethasone added in concentrations of 10 Ϫ10 -10 Ϫ7 m in the absence or presence of (Bt) 2 cAMP after 72 h of incubation. In Fig. 3A is shown a representative immunoblot of such an experiment. The scanned data shown in Fig. 3B are from three independent experiments using tissues from three different human abortuses or pools of lung tissue from several fetuses. The values shown for all treatments are the mean Ϯ sem of three data points from the three independent experiments. The scanned values for each independent experiment were normalized to C/EBP␦ levels in the human fetal lung after 3 days of culture in the absence of glucocorticoids or (Bt) 2 cAMP (0), which were assigned an arbitrary value of 100. As can be seen, dexamethasone caused a dose-dependent induction of C/EBP␦ protein levels in human fetal lung explants. This dose-dependent effect was further augmented in the presence of Bt 2 cAMP. Similar dose-dependent inductive effects were observed after 1 and 5 days in culture (data not shown).
As the highest levels of immunoreactive C/EBP␦ were observed after 1 day of organ culture, it was of interest to analyze changes in C/EBP␦ expression at various time points within the first 24 h of incubation. A densitometric scan of the levels of C/EBP␦ in human fetal lung explants before culture and after incubation in the absence or presence of dexamethasone (10 Ϫ8 m) for 1-24 h are shown in Fig. 4 . The data shown are from one experiment using lung tissues from a midgestation human abortus. The levels of immunoreactive C/EBP␦ in control tissues reached maximal levels after 6 h of incubation and subsequently declined. An inductive effect of dexamethasone was evident as early as 1 h of incubation; levels of C/EBP␦ in the dexamethasone-treated tissues continued to increase, reaching maximal levels after 18 h of incubation.
Immunoreactive C/EBP␦ is primarily localized to nuclei of epithelial cells lining the prealveolar ducts
Immunohistochemical studies were performed to determine the cellular localization of C/EBP␦ protein in human fetal lung before culture and after 12 h of incubation in the absence or presence of dexamethasone (10 Ϫ7 m; Fig. 5 ). Before culture, the midgestation human fetal lung, which is in the early canalicular phase of development, showed trace nuclear staining in occasional stromal and epithelial cells (Fig.  5A) . After 12 h of organ culture in control medium, there was a marked induction of nuclear staining for C/EBP␦, predominantly within epithelial cells lining the prealveolar The scanned values for each independent experiment were normalized to those of (Bt) 2 cAMP-treated tissues on day 5 of culture for that experiment, which were given an arbitrary value of 1500.
ducts and in many of the stromal cells (Fig. 5B) ; however, endothelium and smooth muscle showed no staining. Similar patterns and levels of immunoreactivity were observed in the dexamethasone-treated tissue at this time point (Fig.  5C ) and in control and dexamethasone-treated fetal lung explants after 18 and 24 h of incubation (data not shown); however, diminished staining was apparent in epithelia and stroma after 30 h (data not shown). Persistent immunoreactivity was detected for up to 3 days of culture; however, fewer epithelial and stromal cells were immunoreactive (data not shown). All concurrently processed negative controls were nonreactive (Fig. 5D) . The induction of C/EBP␦ in the cultured human fetal lung tissue preceded enlargement of the prealveolar ducts and the appearance of differentiated type II cells containing lamellar bodies (9) . Although 2-fold differences in the levels of immunoreactive C/EBP␦ were evident in control vs. dexamethasone-treated tissues by immunoblot analysis, these differences were not readily discerned by immunocytochemistry.
Discussion
In the present study we observed that C/EBP␦ gene expression is developmentally regulated in fetal rabbit lung. C/EBP␦ mRNA was detected in the fetal lung tissue as early as 19 days gestation, reaching peak levels by day 28, a time when augmented surfactant glycerophospholipid synthesis is evident (1, 9), SP-A gene transcription reaches maximum levels (17, 32, 34) , and type II cells containing increased numbers of lamellar bodies are present within the alveolar epithelium (35) . Furthermore, we found that immunoreactive C/EBP␦, which is present at low levels in the midgestation human fetal lung before culture, was rapidly induced during spontaneous differentiation in organ culture in se- Ϫ7 M in the absence or presence of (Bt) 2 cAMP. Lung explants from midgestation human abortuses were maintained in organ culture for 3 days in the absence or presence of Dex at concentrations ranging from 10 Ϫ10 -10 Ϫ7 M in the absence or presence of (Bt) 2 cAMP (1 mM) and analyzed for immunoreactive C/EBP␦ by immunoblotting. Shown in A is an autoradiogram of an immunoblot from a representative experiment; B shows scanned data from three independent experiments using tissues from three different human abortuses or pools of lung tissue from several fetuses. The values shown for all treatments are the mean Ϯ SEM of three data points from the three independent experiments. The scanned values for each independent experiment were normalized to values of C/EBP␦ levels in the human fetal lung after 3 days of culture in the absence of glucocorticoids or (Bt) 2 cAMP (0), which were assigned an arbitrary value of 100 .   FIG. 4 . Effect of dexamethasone on the levels of immunoreactive C/EBP␦ in midgestation human fetal lung explants after 1-24 h of organ culture. Midgestation human fetal lung explants were incubated for up to 24 h in control medium or in medium containing dexamethasone (10 Ϫ8 M). C/EBP␦ levels were analyzed by immunoblotting of nuclear extracts (40 g protein) prepared from fetal lung tissues before (time zero) and after 1-24 h of culture. Shown are the values of a densitometric scan of an immunoblot from a single experiment.
rum-free medium and was further increased by treatment with dexamethasone and (Bt) 2 cAMP. The stimulatory effects of dexamethasone were rapid and dose dependent; a stimulatory effect of dexamethasone was evident within 2 h of incubation.
The temporal changes in C/EBP␦ levels in the cultured human fetal lung explants were biphasic. In explants incubated in control medium or in medium containing (Bt) 2 cAMP or dexamethasone, levels of immunoreactive C/EBP␦ were increased to a maximum within 24 h of incubation. Thereafter, in control and (Bt) 2 cAMP-treated tissues, immunoreactive C/EBP␦ declined markedly, so that after 72 h of incubation, levels were less than those in the human fetal lung before culture. By contrast, in fetal lung explants incubated with dexamethasone with or without (Bt) 2 cAMP, the decline in C/EBP␦ protein levels as a function of time in culture was more modest. After 24 h of incubation with dexamethasone and (Bt) 2 cAMP, in combination, an additive stimulatory effect on C/EBP␦ levels was observed compared with that in fetal lung explants incubated with either factor alone; however, after 3 and 5 days of incubation, the stimulatory effects of these agents appeared to be synergistic. This apparent synergism is due to the loss of an inductive effect of cAMP when added to the medium alone despite its continued ability to enhance the stimulatory effect of dexamethasone on C/EBP␦ expression. Immunohistochemical analysis revealed that C/EBP␦ was barely detectable in midgestation human fetal lung before culture. After 12 h of organ culture there was intense nuclear C/EBP␦ immunostaining, localized primarily to epithelial cells lining the prealveolar ducts. These epithelial cells differentiate into type II cells containing numerous lamellar bodies after 2-4 days of culture (9, 11) .
Previously, we observed that treatment of fetal lung explants with agents that increase intracellular cAMP accelerated the rate of type II cell differentiation, induced transcriptional activity of the SP-A gene, and increased the accumulation of SP-A mRNA and protein (6, 11, 18) . Glucocorticoid treatment of rabbit and human fetal lung explants increased surfactant glycerophospholipid synthesis and the rate of SP-A gene transcription (18, 34) . When human fetal lung explants were incubated with dexamethasone and (Bt) 2 cAMP in combination, transcriptional activity of the SP-A gene was synergistically increased (18, 19) . In recent studies using transfected type II cells to functionally map genetic elements that regulate the expression of the human and rabbit SP-A genes, we identified a number of critical regulatory elements within a 400-bp region upstream of the transcription initiation site. An element with sequence similarity to a cAMP-response element (CRE SP-A , TGAC-CTC/TA) (15, 36, 37) , a GT box (GGGGTGGG) (16) , as well as several E box motifs (38) have been identified that are critical for basal and cAMP-induced expression in transfected type II cells. We observed that the proteins that bind to the CRE SP-A appear to change during differentiation of midgestation fetal lung in culture (15) and that neither CREbinding protein nor a related bZIP transcription factor binds to this sequence; rather, a member of the nuclear receptor superfamily likely binds to this site (37) . We also have found that Sp1 together with an unidentified 55-kDa protein are components of the complex that binds to the GT box (16) , and that the helix-loop-helix-leucine zipper proteins upstream stimulatory factors, USF1 (39) and USF2 (Gao, E., Y. Wang, J. L. Alcom, and C. R. Mendelson, unpublished observations), bind to the E box sequences. Additionally, within the Ϫ400 bp region, there are several binding sites for the homeodomain transcription factor thyroid transcription factor-1 (TTF-1) (Li, J., E. Gao, and C. R. Mendelson, unpublished observations), which is essential for development of thyroid, lung, and anterior pituitary (40) . TTF-1 has been reported to mediate expression of the murine SP-A gene in transfected lung cell lines (41) ; in preliminary studies we observed that the TTF-1-binding elements also are critical for cAMP induction of SP-A promoter activity (Li, J., E. Gao, and C. R. Mendelson, unpublished observations). cAMP induction of SP-A promoter activity, therefore, is dependent upon the concerted actions of members of several different transcription factor families bound to response elements within the 5Ј-flanking region of the SP-A gene.
The mechanisms for the glucocorticoid induction of SP-A gene transcription have not been elucidated. We have been unable to find a GRE consensus sequence within or surrounding the rabbit (36) and human (Young, P. P., S. M. McCormick, and C. R. Mendelson, unpublished observations) SP-A genes. Furthermore, in cell transfection studies, we have been unable to identify a functional stimulatory GRE within 2.0 and 1.2 kilobases of DNA flanking the 5Ј-ends of the rabbit (36) and human (Young, P. P., and C. R. Mendelson, unpublished observations) SP-A genes, respectively, or within the first exon and intron of the rabbit SP-A gene (36) . Based on these findings, it is likely that the stimulatory effects of glucocorticoids on transcription of the endogenous SP-A gene are mediated either directly by a GRE(s) that lies outside the confines of the fusion gene constructs tested to date or indirectly through the induction of other transcription factors.
The rapid induction of C/EBP␦ in cultured human fetal lung and its augmentation by glucocorticoids are reminiscent of the time course of C/EBP␦ expression during differentiation of 3T3-L1 preadipocytes to adipocytes. When 3T3-L1 cells were cultured in medium containing the phosphodiesterase inhibitor isobutylmethylxanthine, dexamethasone, and insulin, there was a rapid induction of C/EBP␦ and C/EBP␤ to peak levels on days 2 and 4 of incubation, respectively (25, 42) . Thereafter, C/EBP␦ and -␤ levels declined rapidly, and C/EBP␣ markedly increased in association with the induction of adipocyte-specific mRNAs, lipid accumulation, and cessation of mitotic growth (25) . Isobutylmethylxanthine acted to increase C/EBP␤ gene expression, whereas dexamethasone stimulated C/EBP␦ (25, 42) . It is suggested that C/EBP␤ and/or -␦ act to increase the expression of C/EBP␣, which, in turn, activates adipocyte-specific genes and promotes terminal differentiation. Early during adipocyte differentiation, there also is induction of the adipose-specific nuclear receptor, peroxisome proliferator-activated receptor-␥2 (PPAR␥2); adipogenesis was enhanced by addition of the PPAR␥ activator 5,8,11,14-elcosatetraynoic acid (ETYA) (43) . Interestingly, we observed that PPAR␥1 mRNA and protein levels are induced in human fetal lung explants in association with type II cell differentiation, and that cAMP increases PPAR␥1 mRNA and de novo synthesis of PPAR␥1 protein in type II cells isolated from human and rabbit fetal lung explants (44) .
Recently, it was reported that C/EBP␣ mRNA, which was undetectable in fetal rat lung on day 18 of gestation, was markedly induced by day 20 (27) . It also was found that immunoreactive C/EBP␣ was present in nuclei of type II cells of adult rat lung tissue and declined to undetectable levels within 24 h of culture on plastic dishes, a condition that fails to support the maintenance of type II cell differentiation (27) . SP-C mRNA transcripts are readily detectable in fetal rat lung on day 17 of gestation, SP-A and SP-B mRNA transcripts are first detectable on day 18, and type II cells containing lamellar bodies are first detected on day 19 of gestation (28) . The finding that C/EBP␣ mRNA was detected relatively late in gestation, coordinate with or even after the appearance of differentiated type II cells, suggests that C/EBP␣ may not play a regulatory role in type II cell differentiation and the developmental induction of surfactant glycerophospholipid synthesis.
On the other hand, the findings of the present study indicate that the level of immunoreactive C/EBP␦ increases rapidly during differentiation of human fetal lung in culture, and that C/EBP␦ is predominantly localized to nuclei of epithelial cells lining the prealveolar ducts. These findings together with the observed induction of C/EBP␦ by glucocorticoids and cAMP, agents known to enhance the rate of type II cell differentiation and synthesis of surfactant glycerophospholipids and proteins, suggest that C/EBP␦ may serve as a mediator of the hormonal regulation of surfactant lipoprotein synthesis and type II pneumonocyte differentiation.
